New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 4, 2013
10:57 EDTCWH, GSK, MITK, SSYS, CBSTHigh option volume stocks: GSK CBST MITK CWH SSYS
News For GSK;CBST;MITK;CWH;SSYS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
November 20, 2014
07:33 EDTSSYS3D Systems likely to lower prices amid new competition, says Jefferies
Subscribe for More Information
06:06 EDTCBSTCubist downgraded to Neutral from Outperform at Credit Suisse
Subscribe for More Information
November 19, 2014
16:32 EDTSSYSStratasys appoints ex-Hewlett-Packard Chris Morgan as CMO
Stratasys (SSYS) appointed Chris Morgan as Senior VP and Chief Marketing Officer for Stratasys. Morgan is a 25-year veteran of HP (HPQ).
07:52 EDTGSKInforma Business Information to hold a conference
Subscribe for More Information
November 18, 2014
11:40 EDTMITKMitek Systems management to meet with Benchmark Co.
Meeting to be held in New York on November 25 hosted by Benchmark Co.
07:20 EDTGSKEuro Organization for Research & Treatment of Cancer co-hosts a symposium
Subscribe for More Information
November 17, 2014
17:02 EDTGSKClovis in oncology clinical trial collaboration with GlaxoSmithKline
Subscribe for More Information
13:12 EDTSSYS3D Systems rises after insider buy, Voxeljet slips after downgrade
Subscribe for More Information
10:38 EDTSSYSStratasys announces partnership with Martha Stewart Living Omnimedia
Subscribe for More Information
07:16 EDTCBSTMilken Institute--Faster Cures to hold a conference
Subscribe for More Information
05:32 EDTGSKMedidata announces collaboration with GlaxoSmithKline
Medidata (MDSO) announced the completion of a method development project conducted in partnership with GlaxoSmithKline (GSK) to evaluate the impact of unifying mobile health, or mHealth, devices with cloud-based technologies in a clinical trial setting. The joint initiative assessed the capabilities of mHealth tools and evaluated how they could be used to enable a new model for clinical trial conduct that aligns site and patient needs with faster study execution and reduced costs. The collaborative project, which took place at GSK’s Human Performance Lab, demonstrated that mHealth technologies have the power to comprehensively collect large volumes of objective data that is reliable, secure and analysis-ready, and provides real-time, continuous insight into the well being of patients. All of the data collected was audited and is compliant with FDA regulations. Additionally, the effort indicated that mobile devices can support the long-term goal of lessening the burden on patients participating in studies by streamlining routine procedures, eliminating unnecessary ones and reducing visits to clinical trial sites.
05:16 EDTCBSTCubist to invest about $400M in antibiotics R&D in 2014
Subscribe for More Information
November 14, 2014
14:53 EDTGSKCVS Express Scripts implementing drug price controls, says Cleveland Research
Cleveland Research believes that CVS (CVS) and Express scripts are implementing rebates and price controls on drug. The firm expects the companies to increase their focus on controlling durg prices next year, and adds that they have already itnroduced prior authorization criteria for hepatitis drug. Publicly traded drug companies include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Makers of hepatits c drugs include AbbVie (ABBV) and Gilead (GILD),
07:14 EDTGSKAmerican College of Rheumatology is holding a meeting
2014 ACR/ARHP Annual Meeting is being held in Boston on November 14-19.
November 13, 2014
13:17 EDTSSYSMakerBot acquires Layer by Layer, terms not disclosed
MakerBot, a subsidiary of Stratasys, announced the acquisition of the start-up software company Layer By Layer. The goal of the acquisition of Layer By Layer is to help accelerate MakerBot’s position in the entertainment and 3D printing management spaces, as part of its effort to build a more robust 3D ecosystem.
12:59 EDTGSKApollo plans bid for GSK mature drugs business, Reuters reports
Subscribe for More Information
November 12, 2014
09:16 EDTGSKLigand reports GlaxoSmithKline EU regulatory submission for Revolade
Subscribe for More Information
08:53 EDTGSKGlaxoSmithKline weakness creates buying opportunity, says Argus
After GlaxoSmithKline cut its near-term EPS guidance, Argus still believes that the company's deals with Novartis (NVS) should boost its EPS growth in the years ahead, likely as soon as 2015. The firm thinks the stock is a good value for long-term investors, and it keeps a Buy rating on the shares.
08:18 EDTGSKUBS to hold a conference
Subscribe for More Information
November 10, 2014
16:07 EDTGSKUBS to hold a conference
UBS European Conference is being held in London, England on November 11-12.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use